Leonard H. Calabrese, DO, is a graduate of the Kansas City University of Medicine and Biosciences. He performed his internal medicine training at the Cleveland Clinic Foundation followed by a fellowship in rheumatic and immunologic disease. He has been on staff in that department at the Cleveland Clinic Foundation since 1980.

Dr Calabrese is a professor of medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and vice chair of the Department of Rheumatic and Immunologic Diseases. He is the director of the RJ Fasenmyer Center for Clinical Immunology at the Cleveland Clinic, specializing in diseases of the immune system. He is also the co-director of the Center for Vasculitis Care and Research and holds a joint appointment in the Department of Infectious Diseases.

Dr Calabrese has lectured nationally and internationally on the subjects of clinical immunology, rheumatology, and virology and is the author of more than 400 published peer-reviewed articles, book chapters, and reviews.

Stanley Cohen, MD, is a board-certified rheumatologist and internist who joined Rheumatology Associates in Dallas, Texas, in 1975. Dr. Cohen is a Clinical Professor in the Department of Internal Medicine at UT Southwestern Medical Center and Co-Director of the Division of Rheumatology at Presbyterian Hospital, Dallas. He also is Co-Medical Director of Metroplex Clinical Research Center. He is a past president of the American College of Rheumatology and was honored in 2016 with the designation of Master by the American College of Rheumatology. Dr. Cohen completed a degree in biology from the University of Virginia and received his Doctor of Medicine with honors, from the University of Alabama School of Medicine in Birmingham. He completed an internship and residency in Internal Medicine at Parkland Memorial Hospital, Dallas, Texas, and a fellowship in Rheumatology at UT Southwestern/St. Paul University Hospital.

Alan L. Epstein, MD, is a clinical professor of medicine at the University of Pennsylvania School of Medicine and an attending physician and chief of rheumatology at Pennsylvania Hospital, both in Philadelphia, where he has a private practice in clinical rheumatology.

Dr Epstein received his undergraduate degree from Wesleyan University in CT and his medical degree from Tufts University School of Medicine in MA. He did an internship, medical residency, and chief medical residency at Montefiore Medical Center in NY. Dr Epstein completed his rheumatology fellowship at Montefiore Medical Center and the Albert Einstein College of Medicine in NY.

He is a past president of the Philadelphia Rheumatism Society and a fellow of the American College of Physicians and the American College of Rheumatology (ACR). Dr Epstein previously served on the Professional Development Committee of the ACR and currently serves on the Affiliate Society Council of the ACR. He received the 2010 Joseph Hollander Award from the Pennsylvania Chapter of the Arthritis Foundation for excellence in rheumatology.

Dr Epstein’s past research interests have included drug-induced lupus, systemic lupus erythematosus, and osteoporosis. He lectures widely in the areas of immunology, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, gout, osteoporosis, biosimilars, and anti-inflammatory therapy.

Daniel E. Furst, MD is Professor of Medicine at the University of California (emeritus), Los Angeles (UCLA), Medical Center, David Geffen School of Medicine, Department of Medicine, Division of Rheumatology. He is also Adjunct Professor at the University of Washington, Seattle Washington and Research Professor at the University of Florence, Florence, Italy.

Dr. Furst received his MD from Johns Hopkins University, where he also completed his internship and residency. He completed two fellowships, one in Rheumatology at UCLA Medical Center, and a second in clinical pharmacology at the University of California, San Francisco Medical Center.

After serving as assistant professor of medicine/rheumatology at the UCLA Medical Center and associate professor of internal medicine/Rheumatology at the University of Iowa Carver College of Medicine, Dr. Furst became clinical professor in the Department of Medicine, Division of Rheumatology and Connective Tissue Research at the University of Medicine and Dentistry of New Jersey, and director of AI/P Clinical Research at Ciba Geigy Pharmaceuticals. He subsequently was clinical professor of medicine at the University of Washington, then director of clinical research programs and director of the Arthritis Clinical Research Unit at the Virginia Mason Medical Center. He moved to UCLA in 2002 and became emeritus in 2015. At that time, he took on his several other positions and practices.

Dr. Furst’s research interests center on the clinical pharmacology of antirheumatic drugs and biologics and on the pathophysiology and treatment of progressive systemic sclerosis. He is on the national medical advisory board of the Scleroderma Foundation, the scientific advisory board of the Arthritis Foundation, and the board of directors for the foundation of the Collaboration of Research Rheumatologists of North America. He is a prolific author and an active editor for multiple publications.